| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.5 | 0.004 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.49 | 0.001 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.49 | 0.004 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.45 | 0.008 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.43 | 0.008 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.4 | 0.03 |